Minocycline hydrochloride sustained release tablet and preparation method thereof

A technology of minocycline hydrochloride and sustained-release tablets, which is applied in the field of medicine and can solve the problems such as the increase in the content of minocycline and the increase in time in the differential direction of related substances.

Inactive Publication Date: 2010-09-08
HUZHOU R & D CENT FOR NUTRITION & HEALTH SHANGHAI INST FOR BIOLOGICAL SCI CHINESE ACADEMY OF SCI +1
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In particular, the present invention controls the key parameters in the preparation process of the preparation, which solves the problem that in the preparation process of the sustained-release preparation, as the preparation process increases and the time increases, the content of related substances, especially minocycline, increases. , greatly reducing the content of related substances introduced in the preparation process, especially the anisotropic minocycline, which is more conducive to industrialization and ensures the quality of the product. At the same time, it can also realize the slow and full release of the drug and improve the bioavailability , improve the safety and effectiveness of medication for patients, and better meet the needs of the domestic market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Minocycline hydrochloride sustained release tablet and preparation method thereof
  • Minocycline hydrochloride sustained release tablet and preparation method thereof
  • Minocycline hydrochloride sustained release tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] prescription:

[0025]

[0026] Preparation:

[0027] ①Mixing: Weigh minocycline hydrochloride, hypromellose E50, microcrystalline cellulose 101, and copovidone S630 in the prescribed quantities, and place them in a high-shear granulator to mix evenly;

[0028] ②Granulation: Turn on the stirring paddle, add 40g of water at a constant speed, after the addition is completed, turn on the cutting paddle to granulate, the granulation time is 10 minutes, 16 mesh sieve granulates, and wet granules are obtained;

[0029] ③Drying: the wet granules obtained from ② are dried in a fluidized bed, the temperature of the material is 30°C, the drying time is 2 hours, and the granules are sized by a 20-mesh sieve;

[0030] ④ Tablet compression: Add the magnesium stearate of the recipe amount to the granules obtained in ③, mix well, and compress to obtain tablet cores.

[0031] ⑤Film coating: the Opadry II of the recipe quantity is added to the water at a constant speed under stirri...

Embodiment 2

[0033] prescription:

[0034]

[0035] Preparation method: same as Example 1.

Embodiment 3

[0037] prescription:

[0038]

[0039]

[0040] Preparation method: same as Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a minocycline hydrochloride sustained release tablet and a preparation method thereof. In the technical scheme, the minocycline hydrochloride sustained release tablet is composed of a tablet core and a film coat, the tablet core is composed of minocycline hydrochloride, a sustained release material, a bonding agent, a filling agent and a lubricating agent, the film coat is composed of a film forming material, in the preparation method, the granule is manufactured by means of the high shear wet method and obtained through the drying of a boiling bed, the temperature of the material dried by a fluidized bed is controlled to be 25-35 DEG C, and the moisture content of the granule is controlled to be 2.0-4.0 percent. The invention belongs to the technical field of pharmaceutical preparation, which aims to provide an available preparation process for the minocycline hydrochloride sustained release tablet and greatly reduce the relevant materials introduced druing the preparation by controlling the key parameters in the preparation process. The preparation method of the minocycline hydrochloride sustained release tablet and the method for controlling of the relevant materials aim to develop a sustained release formulation of minocycline hydrochloride, and various specifications can be issued based on the body weight of a patient, thereby reducing the peak valley fluctuation of the blood concentration, effectively controlling the adverse drug reaction, and improving the drug bioavailability.

Description

technical field [0001] The invention relates to a minocycline hydrochloride sustained-release tablet and a preparation method thereof, belonging to the field of medicine. technical background [0002] Minocycline hydrochloride is a semi-synthetic tetracycline broad-spectrum antibiotic with high efficiency and long-term effect. Among tetracycline antibiotics, this product has the strongest antibacterial effect. The antibacterial spectrum is similar to that of tetracycline. It has a strong effect on Gram-positive bacteria including tetracycline-resistant Staphylococcus aureus, Streptococcus, etc. and Neisseria gonorrhoeae among Gram-negative bacteria; generally weaker on Gram-negative bacilli; this product has a strong effect on trachoma Chlamydia and Ureaplasma urealyticum also have better inhibitory effects. The mechanism of action of this product is to bind to the A position of the 30S subunit of the ribosome to prevent the elongation of the peptide chain, thereby inhibit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/22A61K9/36A61K31/65A61K47/38A61P31/04
Inventor 蒋海松王滔王锦刚肖功胜张川川
Owner HUZHOU R & D CENT FOR NUTRITION & HEALTH SHANGHAI INST FOR BIOLOGICAL SCI CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products